Founding Territory Partner – Ophthalmic Device (High Income + Recurring Revenue)

Founding Territory Partner – Ophthalmic Device (High Income + Recurring Revenue) We are building a national team for Optivize, an in‑office dry eye procedure that treats the underlying cause of disease—not just symptoms.

This is a procedural platform, not a one‑time device sale, with built‑in recurring revenue from every treated patient.

Compensation Structured For Experienced, Entrepreneurial Reps $5,000 per device placement ($12K–$15K selling price) 50% of disposable revenue (practice pays $175 per disposable) Ongoing income tied to active accounts No cap on earnings—your income grows with account production and adoption This is not just a transactional sale.

Each placement creates a long‑term revenue stream that grows with usage, giving you both upfront income and recurring earnings from every account you develop.

Example

Sell one Optivize unit per month = $60,000.

Each of your practices performs 20 procedures per month = $561,600.

Total pay = $621,600.

We are looking for special hard‑driving independent reps who want more than one‑time commissions—this is an opportunity to build a portfolio of producing accounts and participate in a rapidly expanding treatment category with no limits on how much they can earn.

Place one per month, coach your docs up to 20 procedures per month, and the second year you are over $1 million/yr.

Candidate Profile We are seeking experienced, independent medical sales reps who already call on ophthalmology, optometry, or other procedure‑based private practices.

You are comfortable working commission‑only and prefer it, because you understand how to build long‑term income from producing accounts—not just one‑time sales.

You have experience with capital equipment or procedural device sales and know how to introduce new technology into a clinic.

You’re not waiting for leads—you create opportunities, open doors, and drive adoption.

Call Points Opening Hook

“Most dry eye treatments, at best, manage symptoms, but don’t address the underlying cause.

Optivize is an in‑office procedure designed to fix that.” Clinical Differentiation

“For the first time ever, we can clear intraglandular biofilm, allowing the tear glands to function again.” Revenue Angle

“This is a procedure‑based platform.

Practices generate between $600 to $900 per treatment, and it’s repeatable.” Workflow Fit

“It integrates easily into existing clinic flow—no major disruption or complex setup.” Close for Next Step

“I’d just like 15 minutes to show you how this could fit into your practice.

If it makes sense, great—if not, no pressure.” Territories Available U.S. territories are open as part of a national rollout.

Early partners will have the opportunity to secure and develop their markets.

Job Type Commission Only – 1099 Category Medical Device #J-18808-Ljbffr